Interferon-γ inhibits nonopsonized phagocytosis of macrophages via an mTORC1-c/EBPβ pathway.

Zengfu Wang,Shuping Zhou,Chenming Sun,Tong Lei,Jianxia Peng,Weiguo Li,Pengbo Ding,Jun Lu,Yong Zhao
DOI: https://doi.org/10.1159/000366421
2015-01-01
Journal of Innate Immunity
Abstract:Bacterial infection often follows virus infection due to pulmonary interferon-gamma (IFN-gamma) production during virus infection, which down-regulates macrophage phagocytosis. The molecular mechanisms for this process are still poorly understood. In the present study, IFN-gamma treatment significantly inhibited the ability of mouse macrophages to phagocytize nonopsonized chicken red blood cells (cRBCs), bacteria and beads in vitro, while it enhanced IgG- and complement-opsonized phagocytosis. IFN-gamma treatment decreased the expression of MARCO (macrophage receptor with collagenous structure) in macrophages. Macrophages showed lower binding to and phagocytic ability of cRBCs when MARCO was blocked with antibody. In addition, IFN-gamma induced high activity of mTOR (mammalian target of rapamycin) and decreased the expression of c/EBP beta (CCAAT enhancer-binding protein beta) in macrophages. Rapamycin, a specific mTOR inhibitor, significantly reversed the inhibitory effect of IFN-gamma on nonopsonized phagocytosis of macrophages and restored c/EBP beta and MARCO expression. Biochemical assays showed that c/EBP beta directly bound to the MARCO gene promoter. Rapamycin significantly hampered the viral-bacterial synergy and protected influenza-infected mice from subsequent bacterial infection. Thus, IFN-gamma inhibited the nonopsonized phagocytosis of macrophages through the nnTOR-c/EBP beta-MARCO pathway. The present study offered evidence indicating that mTOR may be one of the key target molecules for the prevention of secondary bacterial infection caused by primary virus infection. (C) 2014 S. Karger AG, Basel
What problem does this paper attempt to address?